Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Disease Management

“Face up to rosacea”: contributing to the promotion of the doctor-patient dialogue

    • Dermatology and venereology
    • Market & Medicine
    • RX
  • 2 minute read

Launched in 2019, the campaign aims to provide sufferers with knowledge about their chronic inflammatory skin disease and promote empowerment. Web-based disease management tools include the ability to create a personalized patient guide.

Rosacea affects approximately 415 million people worldwide [1]. Characteristic symptoms of this distressing dermatosis include flushing, persistent erythema, and inflammatory lesions. According to data published in 2019, approximately 82% of patients perceive their disease as uncontrollable and in 20% the skin disease leads to substantial limitations in everyday life [2].

Personalized patient guide

“The best consultations are those in which patients are equipped with a list of symptoms and trigger factors and can provide information on previous treatment attempts. With this information, treatment can be tailored to the patient to break the vicious cycle of this chronic inflammatory skin disease,” says Dr. Melinda Gooderham, Medical Director, SKiN Centre for Dermatology, Ontario (Canada). In addition to a questionnaire on individual symptoms and their impact on patients’ daily lives, previous treatments are also addressed. The responses provide the basis for a personalized guide, which can be used for the next consultation. “Each of our patients is unique and has an individual disease history; the more we understand about each patient’s story, the more personalized treatment plans can be offered,” said Linda Stein-Gold, M.D., Division Head of Dermatology, Henry Ford Health System, Michigan (USA).

 

 

Condition worsens visibly if left untreated

Both adult men and women can be affected by rosacea, most often the disease appears after the age of 30. Central areas of the face are mostly affected, such as the cheeks and the area around the nose. Widespread involvement of the eye area (e.g., red, dried, itchy) is also common. The causes of disease are still the subject of research, but several trigger factors are known, including spicy foods, alcohol, emotional stress, sun/UV exposure, hot baths or warm drinks. If left untreated, the condition worsens over time. Individuals who suspect they may be affected by rosacea should consult a dermatologist or other medical caregiver for discussion of treatment options. Because it is a highly visible condition, it is very stigmatized and leads to feelings of shame and fear in sufferers, which can lead to frustration and is associated with negative effects on everyday life.

More information about the project and the benefits for patients is available on the website www.faceuptorosacea.com.

 

 

Source: Galderma

 

Literature:

  1. National Rosacea Society 2018. New Study Finds 415 Million People May Suffer from Rosacea Worldwide. Available at: www.rosacea.org/press/2018/july/new-study-finds-415-million-people-may-suffer-from-rosacea-worldwide, Last accessed October 2019.
  2. Rosacea: Beyond the visible online report, http://hosted.bmj.com/rosaceabeyondthevisible, last accessed October 2019.

 

DERMATOLOGIE PRAXIS 2019; 29(6): 43

Autoren
  • Mirjam Peter, M.Sc.
Publikation
  • DERMATOLOGIE PRAXIS
Previous Article
  • Breast Cancer

10-year data favor partial irradiation

  • Congress Reports
  • Gynecology
  • Oncology
  • Prevention and health care
  • RX
View Post
Next Article
  • Therapy management of multiple sclerosis

Individual, competent, holistic – the right therapy for the MS patient

  • Education
  • Neurology
  • RX
View Post
You May Also Like
View Post
  • 6 min
  • Liver Cancer

Artificial Intelligence in Precision Oncology—Opportunities and Challenges

    • RX
    • Congress Reports
    • Gastroenterology and Hepatology
    • Oncology
    • Studies
View Post
  • 6 min
  • Acute nonspecific back pain

Implementing a biopsychosocial approach

    • RX
    • Congress Reports
    • General Internal Medicine
    • Orthopedics
    • Physical medicine and rehabilitation
    • Studies
    • Surgery
    • Traumatology and trauma surgery
View Post
  • 9 min
  • Psychedelic-assisted therapy

Current status of PAT

    • RX
    • CME continuing education
    • General Internal Medicine
    • Pharmacology and toxicology
    • Psychiatry and psychotherapy
    • Studies
View Post
  • 10 min
  • Neuropathic Pain

Evidence-Based Neuromodulation Based on Clinical Trials and Real-World Data

    • RX
    • CME continuing education
    • Neurology
    • Physical medicine and rehabilitation
    • Studies
    • Surgery
View Post
  • 14 min
  • Fibromyalgia Syndrome

Development, Diagnosis, Epidemiology, and Treatment of a Disease Entity

    • General Internal Medicine
    • CME continuing education
    • Geriatrics
    • Neurology
    • Orthopedics
    • Rheumatology
    • RX
View Post
  • 7 min
  • Juvenile Idiopathic Arthritis

Early Detection and Targeted Treatment in an Interdisciplinary Setting

    • RX
    • Education
    • General Internal Medicine
    • Pediatrics
    • Rheumatology
View Post
  • 6 min
  • Innovative Oral Treatment Options for Psoriasis: Icotrokinra and Zasocitinib

First-class immunomodulation combined with convenience—the data available so far is convincing

    • RX
    • Congress Reports
    • Dermatology and venereology
    • Rheumatology
    • Studies
View Post
  • 8 min
  • Chronic hand eczema: common, long-lasting, and distressing

Non-steroidal anti-inflammatory treatment options are essential for long-term management

    • RX
    • Allergology and clinical immunology
    • Dermatology and venereology
    • Pharmacology and toxicology
    • Studies
  • IBD matters

    Zum Thema
Top CME content
  • 1
    Evidence-Based Neuromodulation Based on Clinical Trials and Real-World Data
  • 2
    Current status of PAT
  • 3
    Development, Diagnosis, Epidemiology, and Treatment of a Disease Entity
  • 4
    Development, Diagnosis, Epidemiology, and Treatment of a Disease Entity
  • 5
    Personalized Treatment Before a Planned Pregnancy

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.